VITAL study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer
(Brigham and Women's Hospital) Brigham and Women's Hospital investigators leading the VITamin D and OmegA-3 TriaL (VITAL) conducted a rigorous placebo-controlled trial over the course of 5.3 years, gleaning a treasure trove of information on the effects of both supplements. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 10, 2018 Category: Cancer & Oncology Source Type: news
AHA: Lipid Guidelines to Headline Meeting
(MedPage Today) -- Exercise, fish oil, Entresto in acute HF, and an anti-inflammatory also in the spotlight (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 8, 2018 Category: Cardiology Source Type: news
Fish Oil Against GI Bleeds; Mammogram CV Screens; Weed and the Heart
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 29, 2018 Category: Endocrinology Source Type: news
Don't Give Up on Fish Oil for CVD Prevention Just Yet Don't Give Up on Fish Oil for CVD Prevention Just Yet
A high dose of at least one pure omega-3 is associated with reduced MACE.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news
Fish oil may curb breast cancer cells growth, spread
A diet containing omega-3 fatty acids found in fish oil may help control the growth and spread of breast cancer cells, according to a study with mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 16, 2018 Category: Consumer Health News Source Type: news
Diets rich in fish oil could slow the spread and growth of breast cancer cells
Omega-3 fatty acids, such as those typically contained in fish oil, may suppress the growth and spread of breast cancer cells in mice. This is according to a new study in the journal Clinical & Experimental Metastasis, which is published under the Springer imprint. According to lead author, Saraswoti Khadge of the University of Nebraska Medical Centre in the US, fatty acids stopped further delayed tumors from forming, and (Source: World Pharma News)
Source: World Pharma News - October 16, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Diets rich in fish oil could slow the spread and growth of breast cancer cells
(Springer) Omega-3 fatty acids, such as those typically contained in fish oil, may suppress the growth and spread of breast cancer cells in mice. This is according to a new study in the journal Clinical& Experimental Metastasis, which is published under the Springer imprint. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2018 Category: International Medicine & Public Health Source Type: news
Fish Oil Drug May Prevent Heart Attack and Strokes in High-Risk Patients
Large doses of an omega-3 fatty acid in fish oil sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes. (Source: NYT Health)
Source: NYT Health - September 26, 2018 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Heart Omega-3 Fatty Acids Diabetes Statins (Cholesterol-Lowering Drugs) Amarin Corp PLC Source Type: news
Can Fish Oil Cut Danger of High-Risk Heart Issues?
The researchers focused on people whose cholesterol levels were controlled with statins, but whose triglyceride levels were still high. Because many smaller studies had not produced much evidence of any benefit in adding fish oil supplements to statin use, the hopes of heart experts were not high. (Source: WebMD Health)
Source: WebMD Health - September 25, 2018 Category: Consumer Health News Source Type: news
Drug company claims fish oil cuts stroke and heart attack risks by 25% - but doctors are skeptical
Amarin claims that its prescription fish oil capsules reduce the risks of heart attack and stroke by 25% based on a global trial of more than 8,000 people, but doctors question the results. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2018 Category: Consumer Health News Source Type: news
Drugmaker touts major heart benefits of fish oil derivative, experts reserve judgment
Irish pharmaceutical company Amarin sent a glowing announcement to investors Monday that its drug Vascepa, a purified fish oil derivative, was linked to a 25% reduced risk of major cardiovascular events such as heart attack and stroke. (Source: CNN.com - Health)
Source: CNN.com - Health - September 25, 2018 Category: Consumer Health News Source Type: news
Fish Oil Drug May Reduce Heart Attack and Stroke Risks for Some
Large doses of an omega-3 fatty acid in fish oil sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes. (Source: NYT Health)
Source: NYT Health - September 25, 2018 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Heart Omega-3 Fatty Acids Diabetes Statins (Cholesterol-Lowering Drugs) Amarin Corp PLC Source Type: news
Drugmaker touts major heart benefits of fish oil derivative
Irish pharmaceutical company Amarin sent a glowing announcement to investors Monday that its drug Vascepa, a purified fish oil derivative, was linked to a 25% reduced risk of major cardiovascular events such as heart attack and stroke. (Source: CNN.com - Health)
Source: CNN.com - Health - September 25, 2018 Category: Consumer Health News Source Type: news
Fish Oil Pill Cuts Heart Dangers for High-Risk Patients
Title: Fish Oil Pill Cuts Heart Dangers for High-Risk PatientsCategory: Health NewsCreated: 9/25/2018 12:00:00 AMLast Editorial Review: 9/25/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 25, 2018 Category: Cardiology Source Type: news
In Blowout, Amarin's Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In Study
The results, if they hold up, are likely to result in many patients getting the medicine, and could upend decades of orthodoxy among cardiologists. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 24, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:AMRN Source Type: news
